The lack of a naturally occurring background signal from fluorine in magnetic resonance
(MR) imaging makes fluorinated compounds potentially attractive candidates for tissue …

Fluorine-19 magnetic resonance imaging is limited by the fact that acquisition times are long
and that high concentrations must be used in order to obtain good signal to noise. A …

19F magnetic resonance imaging (19F MRI) has opened significant new avenues for
investigation of high contrast MRI in vivo. In order to obtain high signal-tonoise images …

Fluorine-19 magnetic resonance imaging (MRI) offers advantages for imaging organs and
tissues. 19 F is readily synthesized into a variety of compounds and offers the potential for in …

Shortly after the introduction of 1H MRI, fluorinated molecules were tested as MR‐detectable
tracers or contrast agents. Many fluorinated compounds, which are nontoxic and chemically …

The development of medical imaging probes for magnetic resonance imaging (MRI) is a
particularly dynamic area of research. At present, many prominent groups are dedicating …

A new perfluorocarbon, PTBD (perfluoro‐2, 2, 2′, 2′‐tetrameth‐yl‐4, 4′‐bis (1, 3‐
dioxolane)), is described for use in 19F MR imaging and spectroscopy. Two‐thirds of the …

In this study sequential 1H and 19F magnetic resonance imaging methods were used to
map the distribution of fluorinated compounds in vivo. An intravenously administered …

Fluorine‐19 (19F) magnetic resonance imaging (MRI) has the potential for a wide range of
in vivo applications but is limited by lack of flexibility in exogenous probe formulation. Most …

Previous fluorine-19 NMR imaging studies have focused primarily on potential applications
of perhuorocarbon liquids (Z-3) and emulsions (4-6) as contrast agents for a variety of …